Impairment of NF-κB nuclear translocation with the recombinant peptide SN50 has been proved to attenuate the elevation in CCND1 expression caused by N-methyl-D-aspartate receptor agonist quinolinic acid in striatal neurons [36], which was largely in line with what we observed in lung cancer cells. The gene discussed is NFKB1; the disease is lung carcinoma.